PET scan can measure early assessment of treatment for breast cancer

Seattle - Non-invasive imaging can measure how well patients with the most common form of breast cancer - oestrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual meeting next week...

Read the whole article on

More from